COVID-19 diagnostics that are intended for home use and those that allow for processing large sample batches are being prioritized by the US Food and Drug Administration review staff according to an agency official.
Timothy Stenzel, director of the device center’s Office of In Vitro Diagnostics and Radiological Health, said during a 10 June...